Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Scott Roberts

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|November 18, 2025
Evaluation of self-mediated alternatives for risk testing education and return of results (eSMARTER) study: A randomized study of methods for returning <i>APOE</i> and pTau-217 resultsClaire M Erickson, Carolyn M Langlois, Elisabeth McCarty Wood, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 21, 2017
A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephoneKurt D Christensen, Wendy R Uhlmann, J Scott Roberts, et al.
Annals of Internal Medicine|January 27, 2016
Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized TrialKurt D Christensen, J Scott Roberts, Peter J Whitehouse, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 27, 2020
Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairmentKurt D Christensen, Jason Karlawish, J Scott Roberts, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerationsMichael M Witte, Norman L Foster, Adam S Fleisher, et al.
The Lancet. Healthy Longevity|November 30, 2025
Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1Jessica B Langbaum, Angela R Bradbury, Brian L Egleston, et al.
Trials|March 21, 2014
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicineJason L Vassy, Denise M Lautenbach, Heather M McLaughlin, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.
Nature|August 8, 2017
Integrative clinical genomics of metastatic cancerDan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Alzheimer'S & Dementia (New York, N. Y.)|November 18, 2025
Evaluation of self-mediated alternatives for risk testing education and return of results (eSMARTER) study: A randomized study of methods for returning <i>APOE</i> and pTau-217 resultsClaire M Erickson, Carolyn M Langlois, Elisabeth McCarty Wood, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 21, 2017
A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephoneKurt D Christensen, Wendy R Uhlmann, J Scott Roberts, et al.
Annals of Internal Medicine|January 27, 2016
Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized TrialKurt D Christensen, J Scott Roberts, Peter J Whitehouse, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 27, 2020
Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairmentKurt D Christensen, Jason Karlawish, J Scott Roberts, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerationsMichael M Witte, Norman L Foster, Adam S Fleisher, et al.
The Lancet. Healthy Longevity|November 30, 2025
Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1Jessica B Langbaum, Angela R Bradbury, Brian L Egleston, et al.
Trials|March 21, 2014
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicineJason L Vassy, Denise M Lautenbach, Heather M McLaughlin, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.
Nature|August 8, 2017
Integrative clinical genomics of metastatic cancerDan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.
Pageof 18